January 14, 2021
U.S. Food and Drug Administration (FDA)
The purpose of this Guide Notice is to notify the FDA recipient community of the change in Federal Financial Reporting (FFR) SF-425 submission requirements and to provide additional implementation details.
Beginning January 1, 2021, respective to FDA awards that require submission of an FFR, FDA recipients will be required to submit the FFR in the Payment Management System (PMS). FFRs submitted on or after January 1, 2021 must use PMS.
This change to FFR submission requirements does not impact the submission timeline. Therefore, FFR due dates as outlined in the Notice of Award remain unchanged.
In alignment with HHS, FDA is implementing this change to allow recipients to report/certify expenditure data once through a single entry point and eliminate the need to report duplicative information across multiple reporting sources.
Additional Implementation Details
Beginning January 1, 2021, FDA recipients must submit required annual and final FFRs in PMS. Recipients who have FFRs that are a work-in-progress in the eRA Commons/FFR module as of January 1, 2021, will need to restart the FFR in PMS.
System Changes that may Impact Recipients as a Result of the Transition to PMS are as follows:
Training sessions offered by PMS for recipients will be posted at this link as they become available: https://pms.psc.gov/training/gr-ffr-training.html.
Questions concerning this Notice may be directed to:
Food and Drug Administration (FDA)
Office of Acquisitions and Grants Services (OAGS)
Grants Management Branch